Home-Based Health Management of COPD Patients

Sara Seifert

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease

Treatments: Behavioral: health coaching

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT02557178

R44HL114162 (U.S. NIH Grant/Contract)

R44HL114162-02A1

Details and patient eligibility

About

Minnesota HealthSolutions Corporation (MHS) proposes to develop and evaluate a program to motivate and monitor people with chronic obstructive pulmonary disease (COPD) to complete home exercise as part of pulmonary rehabilitation (PR). The proposed system has two components: home-based activity monitoring and health coaching. The investigators will conduct a randomized, wait-list controlled clinical study to evaluate the effects of the activity monitoring system and health coaching on quality of life and daily steps.

Enrollment: 154 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of GOLD stage II, III, or IV COPD
• current or previous smoker with at least 10 pack-years of cigarette smoking
• be hospitalized for an exacerbation of COPD

Exclusion criteria

• high likelihood of being lost to follow-up or contact
• inability to provide good data or follow commands
• inability to do mild exercise

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

154 participants in 2 patient groups

Activity Monitor plus Health Coaching

Experimental group

Description:

Device: Actigraph Participants will wear the device daily during weeks 1, 9, and 17. Daily steps and activity will be measured. It will identify if they complete a prescribed exercise regimen. Participants in the intervention condition (wearing the Actigraph) will also receive supportive health coaching to encourage them to exercise.

Treatment:

Behavioral: health coaching

Control

No Intervention group

Description:

Device: Actigraph Participants will wear the device daily during weeks 1, 9, and 17. Daily steps and activity will be measured. It will identify if they complete a prescribed exercise regimen.